25.70
price down icon0.89%   -0.23
pre-market  Vorhandelsmarkt:  26.00   0.30   +1.17%
loading
Schlusskurs vom Vortag:
$25.93
Offen:
$25.83
24-Stunden-Volumen:
382.34K
Relative Volume:
0.47
Marktkapitalisierung:
$11.40B
Einnahmen:
$5.64B
Nettoeinkommen (Verlust:
$305.00M
KGV:
36.82
EPS:
0.698
Netto-Cashflow:
-
1W Leistung:
-1.34%
1M Leistung:
-8.64%
6M Leistung:
-12.50%
1J Leistung:
+7.80%
1-Tages-Spanne:
Value
$25.45
$25.92
1-Wochen-Bereich:
Value
$25.45
$26.32
52-Wochen-Spanne:
Value
$23.69
$31.72

Smith Nephew Plc Adr Stock (SNN) Company Profile

Name
Firmenname
Smith Nephew Plc Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
17,349
Name
Twitter
@smithnephewplc
Name
Nächster Verdiensttermin
2024-08-01
Name
Neueste SEC-Einreichungen
Name
SNN's Discussions on Twitter

Vergleichen Sie SNN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
SNN
Smith Nephew Plc Adr
25.70 11.40B 5.64B 305.00M 0 0.698
Medical Devices icon
ABT
Abbott Laboratories
129.89 221.92B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
93.58 139.43B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
339.59 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
81.80 104.24B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
69.20 40.93B 5.72B 4.17B 259.90M 6.97

Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-12 Herabstufung UBS Buy → Neutral
2024-11-06 Herabstufung Berenberg Buy → Hold
2024-11-01 Herabstufung Deutsche Bank Buy → Hold
2024-07-24 Eingeleitet Deutsche Bank Buy
2024-06-05 Hochstufung UBS Neutral → Buy
2023-11-28 Hochstufung Barclays Underweight → Equal Weight
2023-11-03 Hochstufung JP Morgan Neutral → Overweight
2023-10-31 Hochstufung HSBC Securities Hold → Buy
2023-10-13 Eingeleitet Stifel Hold
2023-08-08 Hochstufung UBS Sell → Neutral
2023-04-27 Herabstufung HSBC Securities Buy → Hold
2023-04-11 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-12-12 Eingeleitet Citigroup Buy
2022-11-28 Herabstufung UBS Neutral → Sell
2022-10-18 Eingeleitet Morgan Stanley Equal-Weight
2022-07-28 Herabstufung Canaccord Genuity Buy → Hold
2022-03-16 Eingeleitet RBC Capital Mkts Outperform
2022-03-15 Eingeleitet RBC Capital Mkts Outperform
2022-03-04 Hochstufung Redburn Sell → Neutral
2021-06-09 Hochstufung Credit Suisse Neutral → Outperform
2020-12-18 Hochstufung Bernstein Mkt Perform → Outperform
2020-12-01 Eingeleitet Barclays Overweight
2020-07-29 Hochstufung BofA Securities Neutral → Buy
2020-06-04 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-04-14 Herabstufung Citigroup Buy → Neutral
2019-11-21 Eingeleitet Citigroup Buy
2019-11-12 Eingeleitet Bernstein Outperform
2019-07-23 Hochstufung Berenberg Hold → Buy
2019-02-08 Herabstufung Exane BNP Paribas Outperform → Neutral
2019-01-02 Herabstufung JP Morgan Overweight → Neutral
2018-12-10 Hochstufung Morgan Stanley Equal-Weight → Overweight
2018-11-01 Bestätigt Canaccord Genuity Buy
2018-01-25 Hochstufung JP Morgan Neutral → Overweight
2017-12-11 Herabstufung Morgan Stanley Overweight → Equal-Weight
2017-10-11 Eingeleitet Canaccord Genuity Buy
2017-02-27 Herabstufung Goldman Buy → Neutral
2017-01-19 Eingeleitet HSBC Securities Hold
2016-12-08 Hochstufung Morgan Stanley Equal-Weight → Overweight
2016-10-06 Herabstufung Berenberg Buy → Hold
2016-02-26 Eingeleitet Cantor Fitzgerald Hold
Alle ansehen

Smith Nephew Plc Adr Aktie (SNN) Neueste Nachrichten

pulisher
Apr 10, 2025

Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.

Apr 10, 2025
pulisher
Mar 12, 2025

UBS cuts Smith & Nephew stock rating to Neutral, sets GBP1.25 target - Investing.com

Mar 12, 2025
pulisher
Mar 04, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 04, 2025
pulisher
Feb 10, 2025

SNN (Smith & Nephew plc ADR) may reap gains as insiders became active recently - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.

Feb 10, 2025
pulisher
Feb 10, 2025

Goldman Downgrades Riskified Ltd (RSKD) to a Sell from a Neutral - Knox Daily

Feb 10, 2025
pulisher
Feb 06, 2025

Smith+Nephew to announce 2024 full year results February 25 - Investing.com

Feb 06, 2025
pulisher
Jan 14, 2025

Smith+Nephew appoints new Non-Executive Director - Investing.com

Jan 14, 2025
pulisher
Dec 02, 2024

Endoprosthesis Market Size to Surpass USD 60.39 Billion by 2032 at a CAGR of 9.86% - GlobeNewswire Inc.

Dec 02, 2024
pulisher
Nov 05, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 05, 2024
pulisher
Oct 31, 2024

Smith & Nephew Earnings: Quarterly Sales Suggest China Weakness Into 2025 - Morningstar

Oct 31, 2024
pulisher
Oct 31, 2024

Smith & Nephew Sees Challenges in China Market - Morningstar

Oct 31, 2024
pulisher
Oct 09, 2024

Smith+Nephew, JointVue partner on ultrasound-based surgical planning for surgical robotics - Mass Device

Oct 09, 2024
pulisher
Oct 02, 2024

Smith+Nephew launches new Legion knee system - Mass Device

Oct 02, 2024
pulisher
Sep 30, 2024

South Korea Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research

Sep 30, 2024
pulisher
Sep 26, 2024

The Best Healthcare Stocks to Buy - Morningstar

Sep 26, 2024
pulisher
Sep 24, 2024

Smith & Nephew Aligns Director Fees with Shares - TipRanks

Sep 24, 2024
pulisher
Sep 20, 2024

China Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research

Sep 20, 2024
pulisher
Sep 19, 2024

Japan Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research

Sep 19, 2024
pulisher
Sep 19, 2024

Smith+Nephew announces first Catalystem hip system procedures - Mass Device

Sep 19, 2024
pulisher
Sep 11, 2024

Smith+Nephew launches Total Ankle patient-matched guides - Mass Device

Sep 11, 2024
pulisher
Sep 04, 2024

Saudi Arabia Antimicrobial Wound Care Dressings Market Size & Outlook, 2030 - Grand View Research

Sep 04, 2024
pulisher
Aug 06, 2024

InfuSystem, Smith+Nephew ink wound therapy distro deal - Mass Device

Aug 06, 2024
pulisher
Aug 01, 2024

Smith+Nephew shares jump on strong H1 results and reaffirmed guidance - Investing.com UK

Aug 01, 2024
pulisher
Jul 16, 2024

Smith+Nephew wins FDA nod for hip system compatible with Cori surgical robot - Mass Device

Jul 16, 2024
pulisher
Jul 12, 2024

Europe First Aid Market Size & Outlook, 2023-2030 - Grand View Research

Jul 12, 2024
pulisher
Jul 05, 2024

Smith & Nephew stock gains on Cevian stake (NYSE:SNN) - Seeking Alpha

Jul 05, 2024
pulisher
Jun 12, 2024

Smith+Nephew launches pre-op planning tech for surgical robotics - Mass Device

Jun 12, 2024
pulisher
Jun 06, 2024

Healthcare Sector - Morningstar

Jun 06, 2024
pulisher
Apr 08, 2024

Here’s Why You Should Invest in Smith & Nephew plc (SNN) - Yahoo Finance

Apr 08, 2024
pulisher
Apr 01, 2024

Smith+Nephew rolls out new chronic wound treatment tech - Mass Device

Apr 01, 2024
pulisher
Mar 13, 2024

7 Robotic Surgery Stocks to Buy for the Future of Healthcare - Yahoo Finance

Mar 13, 2024
pulisher
Feb 27, 2024

Smith+Nephew sales are up 7% as 12-point plan progresses - Mass Device

Feb 27, 2024
pulisher
Feb 12, 2024

Smith+Nephew unveils expanded sports medicine portfolio - Mass Device

Feb 12, 2024
pulisher
Jan 11, 2024

Study backs Smith+Nephew Regeneten bioinductive rotator cuff implant - Mass Device

Jan 11, 2024
pulisher
Nov 10, 2023

Validea Detailed Fundamental AnalysisSNN - Nasdaq

Nov 10, 2023
pulisher
Aug 17, 2023

Smith+Nephew launches hip arthroplasty system in India - Mass Device

Aug 17, 2023
pulisher
Apr 24, 2023

Smith+Nephew unveils handheld digital tensioning device for robotic knee surgery - Mass Device

Apr 24, 2023
pulisher
Nov 21, 2022

Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day - MarketWatch

Nov 21, 2022
pulisher
Oct 24, 2022

Zimmer Biomet Holdings Inc. stock rises Monday, outperforms market - MarketWatch

Oct 24, 2022

Finanzdaten der Smith Nephew Plc Adr-Aktie (SNN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$96.17
price down icon 1.79%
medical_devices PHG
$23.29
price down icon 1.36%
medical_devices STE
$218.78
price down icon 1.55%
$66.11
price down icon 3.59%
$60.48
price down icon 3.03%
medical_devices EW
$69.20
price down icon 3.26%
Kapitalisierung:     |  Volumen (24h):